Cargando…
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus
BACKGROUND: Human respiratory syncytial virus (hRSV) is a highly contagious pathogen and is the most common cause of bronchiolitis and pneumonia for infants and children under one year of age. Worldwide, greater than 33 million children under five years of age are affected by hRSV resulting in three...
Autores principales: | Chung, Dong-Hoon, Moore, Blake P, Matharu, Daljit S, Golden, Jennifer E, Maddox, Clinton, Rasmussen, Lynn, Sosa, Melinda I, Ananthan, Subramaniam, White, E Lucile, Jia, Fuli, Jonsson, Colleen B, Severson, William E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621174/ https://www.ncbi.nlm.nih.gov/pubmed/23302182 http://dx.doi.org/10.1186/1743-422X-10-19 |
Ejemplares similares
-
HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity
por: Chung, Dong Hoon, et al.
Publicado: (2010) -
Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library
por: Severson, William E., et al.
Publicado: (2007) -
Optimization of Potent and
Selective Quinazolinediones:
Inhibitors of Respiratory Syncytial Virus That Block RNA-Dependent
RNA-Polymerase Complex Activity
por: Matharu, Daljit S., et al.
Publicado: (2014) -
Assay development and high-throughput antiviral drug screening against Bluetongue virus
por: Li, Qianjun, et al.
Publicado: (2009) -
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2
por: Jonsson, Colleen B, et al.
Publicado: (2021)